Thymosin Beta-4 Protects Kidneys from Ischemic Injury Through Anti-Inflammatory and Antioxidant Effects
Thymosin β-4 significantly reduced ischemic acute kidney injury in rats by inhibiting oxidative stress, inflammation, apoptosis, and extracellular matrix remodeling, with effects whether given before or during ischemia.
Quick Facts
What This Study Found
Tβ4 significantly reduced caspase-9, MMP-9 activity, hyaluronan, oxidative stress, and inflammation markers while restoring antioxidant levels in both pre-treatment and peri-ischemic treatment groups. Serum creatinine and BUN were significantly reduced (p<0.001).
Key Numbers
32 rats; 4 groups (8/group); 90-min ischemia; TB4 pre- and post-treatment both significantly reduced kidney damage.
How They Did This
Rat model: 4 groups (n=8): sham, I/R (90 min ischemia + 3h reperfusion), Tβ4 pre-treatment + I/R, and Tβ4 during I/R. Measured renal function (Cr, BUN), histology, oxidative stress panel, inflammatory cytokines, caspase-9, MMP-9, and hyaluronan.
Why This Research Matters
Ischemic AKI occurs commonly during surgery and in critical illness. Having an effective protective peptide that works even when given just before reperfusion could transform kidney injury prevention in clinical settings.
The Bigger Picture
Thymosin beta-4 is emerging as a multi-organ protectant — with evidence for corneal, cardiac, and now renal protection. The consistent mechanism of anti-inflammation and anti-apoptosis across organs suggests a fundamental cytoprotective role.
What This Study Doesn't Tell Us
Rat model with relatively short reperfusion period (3h). Long-term kidney recovery not assessed. Optimal human dosing and timing need investigation. Tβ4 is not yet approved for clinical use.
Questions This Raises
- ?Could Tβ4 be given prophylactically before surgeries with high AKI risk?
- ?How does Tβ4's kidney protection compare to existing strategies like remote ischemic preconditioning?
- ?Would Tβ4 protect against other forms of AKI beyond ischemic injury?
Trust & Context
- Key Stat:
- p<0.001 significance level for Tβ4's reduction of kidney injury markers including creatinine, BUN, and inflammatory cytokines
- Evidence Grade:
- Well-designed preclinical study with multiple outcome measures and two treatment timing groups. Strong effect sizes but requires human validation.
- Study Age:
- Published in 2021. Thymosin beta-4 continues to be investigated for organ protection across multiple systems.
- Original Title:
- The Protective Effects of Thymosin-β-4 in a Rat Model of Ischemic Acute Kidney Injury.
- Published In:
- Journal of investigative surgery : the official journal of the Academy of Surgical Research, 34(6), 601-609 (2021)
- Authors:
- Aksu, Ugur, Yaman, Onur M, Guner, Ibrahim, Guntas, Gulcan, Sonmez, Fuat, Tanriverdi, Gamze, Eser, Mediha, Cakiris, Aris, Akyol, Sibel, Seçkin, İsmail, Uzun, Hafize, Yelmen, Nermin, Sahin, Gulderen
- Database ID:
- RPEP-05257
Evidence Hierarchy
Frequently Asked Questions
What causes ischemic kidney injury?
Ischemic AKI occurs when blood flow to the kidneys is temporarily interrupted — during surgery, trauma, or severe illness. When blood flow returns (reperfusion), it paradoxically causes additional damage through oxidative stress and inflammation.
Why is it important that Tβ4 works when given during ischemia?
In many clinical situations, kidney ischemia can't be predicted in advance. A treatment that works when given at the time of injury (not just as prevention) would be far more useful in emergency and surgical settings.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05257APA
Aksu, Ugur; Yaman, Onur M; Guner, Ibrahim; Guntas, Gulcan; Sonmez, Fuat; Tanriverdi, Gamze; Eser, Mediha; Cakiris, Aris; Akyol, Sibel; Seçkin, İsmail; Uzun, Hafize; Yelmen, Nermin; Sahin, Gulderen. (2021). The Protective Effects of Thymosin-β-4 in a Rat Model of Ischemic Acute Kidney Injury.. Journal of investigative surgery : the official journal of the Academy of Surgical Research, 34(6), 601-609. https://doi.org/10.1080/08941939.2019.1672841
MLA
Aksu, Ugur, et al. "The Protective Effects of Thymosin-β-4 in a Rat Model of Ischemic Acute Kidney Injury.." Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2021. https://doi.org/10.1080/08941939.2019.1672841
RethinkPeptides
RethinkPeptides Research Database. "The Protective Effects of Thymosin-β-4 in a Rat Model of Isc..." RPEP-05257. Retrieved from https://rethinkpeptides.com/research/aksu-2021-the-protective-effects-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.